Modular Peptide System E – Multi-Peptide Complex

Product Name: Modular Peptide System E – Multi-Peptide Complex Module Classification: Composite Module Product Information: Formulation Type: Multi-Peptide Serum-Emulsion Volume: 30 mL pH Range: 5.0–5.3 Packaging: Opaque Airless UV-Protective Container with Low-Oxygen Headspace Testing Methodology: HPLC-UV-MS Analytical Verification: ISO/IEC 17025 Accredited Laboratory System Compatibility: Phase 1, Complete Configuration, Standalone Evaluation Analytical Composition: Acetyl Octapeptide-3 (SNAP-8): 0.06% Tetrapeptide-21: 0.05% AHK-Cu: 0.02% Total Peptide Content: 0.13% Product Description: Module E is one of five products within PHP’s Modular Peptide System, a modular framework of peptide formulations designed for research evaluation. Researchers may evaluate individual modules independently or as part of three structured configurations: Phase 1, Phase 2, or the Complete Configuration. Module E is a multi-component peptide serum-emulsion integrating three peptides drawn from three distinct structural classes: an acetylated octapeptide, a tetrapeptide, and a copper-coordinated peptide complex. The composition represents the most analytically complex individual product within the modular framework and was designed to integrate multiple peptide classes into a single composite formulation. Composition is independently verified through ISO/IEC 17025-accredited analytical testing using HPLC-UV-MS methodology. Batch-specific Certificates of Analysis are available through the COA-Topicals library. The COA reflects simultaneous multi-peptide verification across three distinct structural classes. Research Framework: Multi-peptide composite architecture Three peptides spanning three structural classes Most analytically complex formulation in the modular framework Compatible with Phase 1 and Complete Configuration May be evaluated independently or within broader comparative frameworks Incorporates both free peptides and a copper-coordinated peptide complex Formulation Characteristics: Acetyl Octapeptide-3 (SNAP-8) incorporated at 0.06% Tetrapeptide-21 incorporated at 0.05% AHK-Cu incorporated at 0.02% Three-peptide composition selected to maintain analytically meaningful concentrations across all components Narrow pH operating range required to support multi-peptide compositional stability Low-oxygen headspace packaging selected to support formulation integrity Most protective packaging configuration utilized within the modular framework Comparative Position Within The System: Within the modular framework, Module E functions as the composite composition. Unlike Modules A, B, and D, which are built around one dominant peptide architecture, Module E integrates three peptides from three separate structural classes within a single formulation. This creates the broadest peptide-class diversity of any individual module within the system and positions Module E as the central composite component of Phase 1. Composite Formulation Design: Three peptides represent the upper compositional complexity within the modular framework. This composition was intentionally designed to maintain each peptide at an analytically meaningful concentration while preserving measurable representation from multiple peptide classes within a single formulation. AHK-Cu is included at 0.02%, distinct from the 0.10% concentration utilized in Module D, enabling comparative evaluation of the same copper-coordinated peptide at different analytical levels across the system. Product Specifications: Peptide Count: 3 Total Peptide Content: 0.13% Primary Structural Classes: Acetylated Octapeptide, Tetrapeptide, Copper-Coordinated Peptide Delivery Matrix: Multi-Peptide Serum-Emulsion Packaging: Opaque Airless UV-Protective with Low-Oxygen Headspace pH Range: 5.0–5.3 Batch Verification: ISO/IEC 17025 HPLC-UV-MS Compliance Notice: Modular Peptide System E is FOR RESEARCH USE ONLY — NOT FOR HUMAN OR VETERINARY USE. This product is not a drug, cosmetic, food, or dietary supplement and has not been evaluated or approved by the U.S. Food and Drug Administration. It is intended solely for lawful in vitro research and not for any human or animal use. By purchasing this product, buyer represents and warrants that it will be used exclusively for lawful in vitro research in compliance with all applicable laws and regulations, and assumes all responsibility for any use inconsistent with this notice.